How Data‑Driven Design Is Reshaping RNA Therapeutics
The future of mRNA development is no longer purely biological – it is computational, predictive, and data‑driven.
Across the industry, artificial intelligence is transforming how mRNA sequences are designed, optimized, and validated. From generative RNA language models to closed‑loop Design‑Make‑Test workflows, AI is rapidly becoming a competitive necessity rather than a future ambition.
Recognising this shift, the 6th mRNA‑Based Therapeutics Summit introduces a brand‑new Inaugural AI & mRNA Design Day, putting machine learning at the heart of therapeutic innovation.
Why AI Is Now Essential for mRNA Innovation
As mRNA modalities become more complex – spanning circular RNA, self‑amplifying RNA, and in vivo CAR programming – traditional trial‑and‑error development is no longer scalable.
AI enables teams to:
Predict translation efficiency and stability
Optimize UTRs and sequence architecture
Reduce iteration cycles and experimental cost
Connect sequence design directly to functional outcomes
Simply put: AI shortens timelines and expands what’s biologically possible.
Inside the Inaugural AI & mRNA Design Day
This dedicated pre‑conference focus day dives into real‑world deployment of AI across mRNA discovery and development.
Featured topics include:
- Deep‑learning‑guided mRNA sequence optimization
- RNA language models for vaccine and therapeutic design
- AI‑driven Design‑Make‑Test‑Learn workflows
- Integrating experimental feedback to improve prediction accuracy
You’ll hear from AI and computational leaders at organisations including:
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights on the mRNA innovations during our packed agenda, interactive roundtables, and new CEOs & investor panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of mRNA biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.